The epidermal platelet-activating factor receptor augments chemotherapy-induced apoptosis in human carcinoma cell lines.
about
Targeted lipidomics - advances in profiling lysophosphocholine and platelet-activating factor second messengersTopical application of a platelet activating factor receptor agonist suppresses phorbol ester-induced acute and chronic inflammation and has cancer chemopreventive activity in mouse skinAnti-apoptotic actions of the platelet-activating factor acetylhydrolase I alpha2 catalytic subunitUVB Generates Microvesicle Particle Release in Part Due to Platelet-activating Factor SignalingThe expression of platelet-activating factor receptor modulates the cisplatin sensitivity of ovarian cancer cells: a novel target for combination therapy.Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor.Expression of the platelet-activating factor receptor enhances benzyl isothiocyanate-induced apoptosis in murine and human melanoma cellsExpression of PAFR as part of a prosurvival response to chemotherapy: a novel target for combination therapy in melanoma.Platelet-Activating Factor-Receptor and Tumor Immunity.Radiation therapy generates platelet-activating factor agonistsEpidermal growth factor induces platelet-activating factor production through receptors transactivation and cytosolic phospholipase A2 in ovarian cancer cells.Amyloid toxicity and platelet-activating factor signaling.Effect of osmotic shock and urea on phosphatidylserine scrambling in thrombocyte cell membranes.Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.Acetylsalicylic acid inhibits the growth of melanoma tumors via SOX2-dependent-PAF-R-independent signaling pathway.The relation between sphingomyelinase activity, lipid peroxide oxidation and NO-releasing in mice liver and brain.
P2860
Q27008183-2D9305C9-2A42-4B12-8175-D4BC559A43CAQ28544768-1193423A-B311-46EA-A5FF-2D4188CE752CQ28564311-A442010D-9929-42B3-AB52-F09EF6EB38C1Q33664877-13355051-E5D8-4823-B0EF-34740339068AQ33994379-63E56FD2-4C14-4B01-896D-67C519B7ACB7Q34613089-28EF9B20-DAC5-4C05-BF34-E2FAF9FCBABBQ35628374-43970AA7-125C-4340-B294-A934474A07CEQ35915423-A5DA4378-EC97-4BFE-BB64-169B1CF0A8DFQ36935937-F1E9D053-D6A4-43D3-ACD2-3ECBA72A7F45Q37190440-6F07C901-6EFE-41B4-8A43-35416D152CAAQ37734315-8E7E3BD0-E366-4D8F-BDB0-33BAED9FA88CQ38061367-2F3BD5F4-1C1C-4D84-B669-65AA661C8D06Q38345628-F6446813-4866-487A-9542-E0793C4C34D6Q39972669-A6711A43-7D3A-4DD4-BC05-08994B6E0302Q41472852-DDAA2F2D-B229-4C0B-96CB-44A58B527B10Q46753598-5047D379-BD49-47F1-9E82-FE26C953AF40
P2860
The epidermal platelet-activating factor receptor augments chemotherapy-induced apoptosis in human carcinoma cell lines.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The epidermal platelet-activat ...... in human carcinoma cell lines.
@en
type
label
The epidermal platelet-activat ...... in human carcinoma cell lines.
@en
prefLabel
The epidermal platelet-activat ...... in human carcinoma cell lines.
@en
P2093
P2860
P356
P1476
The epidermal platelet-activat ...... in human carcinoma cell lines
@en
P2093
Dan Spandau
Davina Lewis
Michael D Southall
Mohammed Al-Hassani
Qiaofang Yi
P2860
P304
16614-16621
P356
10.1074/JBC.M211287200
P407
P577
2003-02-24T00:00:00Z